ORIC Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts $9.99 +0.10 (+1.01%) (As of 09/16/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (Aug. 12) -$0.45 Missed By -$0.03 Consensus EPS (Aug. 12) -$0.42 Get ORIC Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ORIC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueORIC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ORIC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. ORIC Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.46)($0.43)($0.45)Q2 20242($0.42)($0.41)($0.42)Q3 20242($0.49)$0.45($0.02)Q4 20242($0.51)$0.46($0.03)FY 20248($1.88)$0.07($0.91)Q1 20252($0.53)($0.47)($0.50)Q2 20252($0.54)($0.49)($0.52)Q3 20252($0.56)($0.51)($0.54)Q4 20252($0.58)($0.52)($0.55)FY 20258($2.21)($1.99)($2.10)ORIC Earnings Date and InformationORIC Pharmaceuticals last announced its quarterly earnings data on August 12th, 2024. The reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by $0.03. ORIC Pharmaceuticals has generated ($1.80) earnings per share over the last year (($1.80) diluted earnings per share). Earnings for ORIC Pharmaceuticals are expected to decrease in the coming year, from ($1.78) to ($2.06) per share. ORIC Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More ORIC Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/4/2024(Estimated)------- 8/12/2024Q2 2024($0.42)($0.45)($0.03)($0.45)--5/6/2024Q1 2024($0.44)($0.37)+$0.07($0.37)-- 3/11/2024-($0.49)($0.49)-($0.49)-- 11/6/2023Q3 2023($0.46)($0.44)+$0.02($0.44)-- 8/10/2023Q2 2023($0.58)($0.50)+$0.08($0.50)-- 5/8/2023Q1 2023($0.54)($0.53)+$0.01($0.53)-- Get the Latest News and Ratings for ORIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ORIC Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/16/2023Q4 2022($0.56)($0.52)+$0.04($0.52)--11/7/2022Q3 2022($0.55)($0.63)($0.08)($0.63)--8/11/2022Q2 2022($0.60)($0.51)+$0.09($0.51)--5/9/2022Q1 2022($0.57)($0.59)($0.02)($0.59)-- 3/21/2022Q4 2021($0.61)($0.58)+$0.03($0.58)-- 11/8/2021Q3 2021($0.58)($0.47)+$0.11($0.47)--8/10/2021Q2 2021($0.49)($0.57)($0.08)($0.57)--5/6/2021Q1 2021($0.48)($0.45)+$0.03($0.45)-- 3/22/2021Q4($0.4640)($0.84)($0.3760)($0.84)--11/5/2020Q3 2020($0.39)($0.84)($0.45)($0.84)-- 8/5/2020Q2 2020($0.37)($0.51)($0.14)($0.51)-- 5/20/2020Q1($0.2640)($4.46)($4.1960)($4.46)-- ORIC Pharmaceuticals Earnings - Frequently Asked Questions When is ORIC Pharmaceuticals's earnings date? ORIC Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on ORIC's earnings history. Did ORIC Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) missed the analysts' consensus estimate of ($0.42) by $0.03 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. ORIC's actual earnings. How much profit does ORIC Pharmaceuticals generate each year? ORIC Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$100.70 million. ORIC has generated -$1.80 earnings per share over the last four quarters. What is ORIC Pharmaceuticals's EPS forecast for next year? ORIC Pharmaceuticals's earnings are expected to decrease from ($1.78) per share to ($2.06) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PHAT Earnings Date KPTI Earnings Date ARQT Earnings Date BTAI Earnings Date SUPN Earnings Date ARWR Earnings Date PTGX Earnings Date AMRX Earnings Date ACAD Earnings Date IOVA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:ORIC) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredGrab this ETF paying a huge 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | SponsoredThe $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ORIC Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
